The recall was issued due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Date 06/2020.Torrent's recall was expanded on Jan. 22 to include 10 additional lots of losartan potassium tablets, and six lots of losartan potassium and hydrochlorothiazide tablets. 1/1 Drug: Losartan Potassium; Strength: 100 mg; Pill Imprint: LU P23; Color: White; Shape: Capsule-shape; View Images & Details. In April, the agency  released a list of 40 blood pressure medications it says are free from contamination. Read more about Lupin recalls blood pressure drug from US on Business Standard. Records from drug manufacturers show the impurity may have been in the valsartan products for up to 4 years. HOW TO KNOW IF YOU HAVE KIDNEY PROBLEMS [Free dialysis video training] - Duration: 22:16. Last Updated at January 20, 2013 23:53 IST Search Results; Search Again; Results 1 - 1 of 1 for "LU P23" Sort by: Results: LU P23. The FDA estimates that if 8,000 people took the highest valsartan dose, which is 320 milligrams, from recalled batches every day for 4 years, there would likely only be one additional case of cancer over the life of those 8,000 people.For context, 1 in 3 people in the United States will be diagnosed with cancer in their lifetime.A common thread among all of these recalls is that the drugs, or ingredients in the drugs, were all made in China or India.American drug companies since the 1990s have increasingly used factories in other countries to manufacture their products. The problems have become so widespread that on March 12 the FDA prioritized approval of a new generic of valsartan to help relieve shortages of the drug. An additional 3.6 million prescriptions were written for irbesartan that year. Here’s what you need to know.In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. The total value of the batch is insignificant. Teva expanded this recall on June 10, 2019, with another six lots of losartan potassium USP tablets in 50mg and 100mg strength.  On May 4, Vivimed Life Sciences Pvt Ltd recalled 19 lots of losartan potassium tablets in 25 mg, 50 mg and 100 mg doses. The FDA needs to finish its investigation and develop a plan to prevent further contamination. LU P23 (Losartan Potassium 100 mg) Pill with imprint LU P23 is White, Capsule-shape and has been identified as Losartan Potassium 100 mg. About 40% of finished medications are made overseas, the Government Accountability Office says. Business Standard is happy to inform you of the launch of "Business Standard Premium Services"As a premium subscriber you get an across device unfettered access to a range of services which include:Welcome to the premium services of Business Standard brought to you courtesy FIS. The drugs were made in India and distributed by Heritage Pharmaceuticals of East Brunswick, NJ. Pharmacy Update 13,196 views. 6:23. Drug firm Lupin is recalling one batch of Losartan Potassium Tablets, used in treating high blood pressure, from the US market for exceeding permissible impurity level, the US health regulator said. And, he says, some Craig Beavers, PharmD, cardiovascular clinical pharmacy coordinator, University of Kentucky Medical Center.FDA.gov: "Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the agency’s list of known nitrosamine-free valsartan and ARB class medicines, as part of agency’s ongoing efforts to resolve ongoing safety issue;" "Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)," "Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)," "FDA approves a new generic valsartan," “UPDATED:ADDITIONAL LOTS ADDED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets,” “FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm’s already recalled products,” “Analysis of N-nitrosodimethylamine (NDMA) Levels in Recalled Valsartan in the U.S.,” “FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan,” “Irbesartan products under recall - Updated October 29, 2018,” “Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API),” “Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API),” “Valsartan products not currently recalled - Updated December 4, 2018,” “Valsartan products under recall - Updated December 4, 2018.”Robert Handfield, director of Supply Chain Resource Cooperative, North Carolina State University.ClinCal.com: “Valsartan Drug Usage Statistics, United States, 2006 – 2016.”Public Interest Research Group: "Blood pressure medication recalled for 75th time in 8 months.